Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Asset disposition
Inv. presentation
Acq. announced
|
|
OPKO HEALTH, INC. (OPK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/03/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/19/2020 |
SC 13D/A
| OPKO HEALTH, INC. reports a 5.4% stake in Cocrystal Pharma, Inc. |
| 03/20/2020 |
SC 13D/A
| HSIAO JANE PH D reports a 5.2% stake in OPKO Health, Inc. |
| 03/10/2020 |
SC 13D/A
| Opko Health, Inc. reports a 7.8% stake in Cocrystal Pharma, Inc. |
| 11/22/2019 |
SC 13D/A
| Opko Health, Inc. reports a 10.5% stake in Cocrystal Pharma, Inc. |
| 11/01/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/01/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/23/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/23/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/02/2019 |
SC 13D/A
| Opko Health, Inc. reports a 4.5% stake in Neovasc Inc. |
| 09/30/2019 |
SC 13D/A
| Opko Health, Inc. reports a 3.7% stake in VBI Vaccines Inc. |
| 03/22/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 35.7% stake in OPKO Health, Inc. |
| 03/20/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 35.7% stake in OPKO Health, Inc. |
| 03/13/2019 |
SC 13D/A
| Opko Health, Inc. reports a 6.8% stake in VBI Vaccines, Inc. |
| 11/20/2018 |
SC 13D/A
| HSIAO JANE PH D reports a 5.8% stake in OPKO Health, Inc. |
| 11/20/2018 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 37.3% stake in OPKO Health, Inc. |
| 12/27/2017 |
SC 13D/A
| Opko Health, Inc. reports a 4.7% stake in Eloxx Pharmaceuticals, Inc. |
| 11/14/2017 |
SC 13D/A
| Opko Health, Inc. reports a 31.4% stake in Sevion Therapeutics, Inc. |
| 11/01/2017 |
SC 13D/A
| Opko Health, Inc. reports a 16.6% stake in VBI Vaccines, Inc. |
| 09/20/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/10/2017 |
SC 13D/A
| RXi Pharmaceuticals Corp reports a 3.4% stake in RXi Pharmaceuticals Corporation |
| 03/22/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/21/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 10/11/2012 |
SC 13D/A
| Frost Group, LLC reports a 48.6% stake in OPKO Health, Inc. |
| 09/13/2012 |
SC 13D/A
| Opko Health, Inc. reports a 19.7% stake in SORRENTO THERAPEUTICS, INC. |
| 10/24/2011 |
SC 13D/A
| Opko Health, Inc. reports a 47% stake in OPKO Health, Inc. |
| 03/28/2011 |
SC 13D/A
| Opko Health, Inc. has filed a Schedule 13D for OPKO Health, Inc. |
| 10/01/2009 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 10/01/2009 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/19/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
|
|